- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
AVEO Pharmaceuticals (NASDAQ:AVEO), Quotes and News Summary
AVEO Pharmaceuticals (NASDAQ: AVEO)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.250 | -0.300 | -0.0500 | ||||
| REV | 20.650M | 20.920M | 270.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
AVEO Pharmaceuticals Questions & Answers
You can purchase shares of AVEO Pharmaceuticals (NASDAQ: AVEO) through any online brokerage.
Other companies in AVEO Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Impel Pharmaceuticals (NASDAQ:IMPL), Inozyme Pharma (NASDAQ:INZY) and Voyager Therapeutics (NASDAQ:VYGR).
The latest price target for AVEO Pharmaceuticals (NASDAQ: AVEO) was reported by HC Wainwright & Co. on Monday, July 12, 2021. The analyst firm set a price target for 19.00 expecting AVEO to rise to within 12 months (a possible 188.75% upside). 1 analyst firms have reported ratings in the last year.
The stock price for AVEO Pharmaceuticals (NASDAQ: AVEO) is $6.58 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for AVEO Pharmaceuticals.
AVEO Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for AVEO Pharmaceuticals.
AVEO Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.